HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Joachim Sieper Selected Research

Back Pain (Backache)

8/2015Development of an ASAS-endorsed recommendation for the early referral of patients with a suspicion of axial spondyloarthritis.
3/2014Spinal inflammation in the absence of sacroiliac joint inflammation on magnetic resonance imaging in patients with active nonradiographic axial spondyloarthritis.
10/2013ASAS modification of the Berlin algorithm for diagnosing axial spondyloarthritis: results from the SPondyloArthritis Caught Early (SPACE)-cohort and from the Assessment of SpondyloArthritis international Society (ASAS)-cohort.
10/2013Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study.
6/2013Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1).
7/2012How to screen for axial spondyloarthritis in primary care?
5/2012Referral strategies for early diagnosis of axial spondyloarthritis.
11/2011Evaluation of 2 screening strategies for early identification of patients with axial spondyloarthritis in primary care.
3/2009The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort.
11/2008Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Joachim Sieper Research Topics

Disease

67Ankylosing Spondylitis
12/2015 - 01/2002
18Inflammation
04/2015 - 08/2003
13Back Pain (Backache)
08/2015 - 02/2006
10Sacroiliitis
08/2015 - 11/2007
8Rheumatoid Arthritis
04/2013 - 01/2002
7Arthritis (Polyarthritis)
08/2015 - 07/2003
6Psoriatic Arthritis
04/2015 - 01/2002
6Pain (Aches)
03/2014 - 03/2004
5Reactive Arthritis (Reiter Disease)
11/2006 - 08/2003
4Infection
06/2015 - 07/2006
4Necrosis
04/2014 - 02/2003
3Psoriasis (Pustulosis Palmaris et Plantaris)
08/2015 - 05/2012
2Uveitis
08/2015 - 03/2009
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
08/2015 - 12/2011
2Osteitis
02/2015 - 01/2008
2Spondylarthritis (Spinal Arthritis)
01/2014 - 07/2008
2Autoimmune Diseases (Autoimmune Disease)
06/2013 - 11/2011
2Crohn Disease (Crohn's Disease)
12/2011 - 02/2003
2Low Back Pain (Lumbago)
11/2007 - 02/2006
1Neutropenia
06/2015
1Hypertrophy
01/2015
1Osteoarthritis
01/2015
1Neoplasms (Cancer)
11/2012
1Postoperative Pain
10/2011
1Anoxia (Hypoxia)
01/2011
1Respiratory Tract Infections (Respiratory Tract Infection)
06/2009
1Headache (Headaches)
06/2009
1Fever (Fevers)
01/2008
1Rheumatic Diseases (Rheumatism)
11/2006
1Edema
01/2006
1Arthralgia (Joint Pain)
12/2004
1Tenosynovitis
10/2004

Drug/Important Bio-Agent (IBA)

20Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2015 - 01/2002
16C-Reactive ProteinIBA
04/2015 - 02/2005
13infliximab (Remicade)FDA Link
04/2014 - 01/2002
12TNFR-Fc fusion protein (etanercept)FDA Link
02/2015 - 01/2002
12HLA-B27 Antigen (HLA B27 Antigen)IBA
08/2014 - 01/2004
11adalimumab (Humira)FDA Link
07/2015 - 07/2003
9AntigensIBA
08/2015 - 03/2003
8Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
04/2015 - 04/2007
5O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA
10/2013 - 02/2006
4Antirheumatic Agents (DMARD)IBA
05/2012 - 01/2002
3Interleukin-17 (Interleukin 27)IBA
12/2015 - 01/2011
3Transcription Factors (Transcription Factor)IBA
04/2015 - 11/2011
3N 30IBA
10/2014 - 06/2009
3CytokinesIBA
06/2013 - 10/2004
3PeptidesIBA
03/2005 - 08/2003
2Interleukin-6 (Interleukin 6)IBA
06/2015 - 01/2011
2Interleukin-23 (Interleukin 23)IBA
06/2013 - 01/2009
2Sulfasalazine (Azulfidine)FDA LinkGeneric
10/2012 - 07/2003
2Escherichia coli ProteinsIBA
09/2012 - 12/2011
2Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2008 - 03/2004
2Adrenal Cortex Hormones (Corticosteroids)IBA
02/2005 - 12/2004
1Alanine Transaminase (SGPT)IBA
06/2015
1ResistinIBA
03/2015
1AdipokinesIBA
03/2015
1Nicotinamide PhosphoribosyltransferaseIBA
03/2015
1AdiponectinIBA
03/2015
1Carbon MonoxideIBA
01/2015
1Matrix Metalloproteinase 13IBA
01/2015
1Collagen Type XIBA
01/2015
1beta CateninIBA
01/2015
1Proteins (Proteins, Gene)IBA
01/2015
1OsteocalcinIBA
01/2015
1monoclonal antibody CNTO 1275 (CNTO 1275)FDA Link
05/2014
1InterleukinsIBA
02/2014
1tocilizumabFDA Link
01/2014
1Interleukin-12 (IL 12)IBA
06/2013
1rituximab (Mabthera)FDA Link
02/2013
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
11/2012
1Virulence Factors (Pathogenicity Factors)IBA
09/2012
1Labetalol (Normodyne)FDA LinkGeneric
10/2011
1Opioid Receptors (Opioid Receptor)IBA
10/2011
1Neurotransmitter Agents (Neurotransmitter)IBA
10/2011
1Adrenergic Receptors (Adrenergic Receptor)IBA
10/2011
1Opioid Peptides (Opioid Peptide)IBA
10/2011
1Morphine (MS Contin)FDA LinkGeneric
10/2011
1Opioid Analgesics (Opioids)IBA
10/2011
1phorbolIBA
01/2011
1IonomycinIBA
01/2011
1EnterotoxinsIBA
01/2011
1Biological Markers (Surrogate Marker)IBA
07/2009
1golimumabFDA Link
11/2008
1celecoxib (Celebrex)FDA Link
07/2008
1Interleukin-1 (Interleukin 1)IBA
01/2008
1AntibodiesIBA
03/2007
1InterferonsIBA
11/2006
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
11/2006
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
11/2006
1Immunoglobulin G (IgG)IBA
07/2006
1Eosine Yellowish-(YS) (Eosin)IBA
01/2006
1Hematoxylin (Haematoxylon)IBA
01/2006
1Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
12/2004
1Aggrecans (Aggrecan)IBA
10/2004
1EpitopesIBA
10/2004

Therapy/Procedure

2Biological Therapy
01/2003 - 01/2002
1Off-Label Use
04/2013
1Patient-Controlled Analgesia (Analgesia, Patient Controlled)
10/2011
1Subcutaneous Injections
11/2008
1Retreatment
03/2007